Risk Factors and Treatment Strategies for Anastomotic Ulcers in Pediatric Intestinal Failure

Priyanka V Chugh1, Emily K Nes1, Hajar Fénnich1

  • 1Department of Surgery, Boston Children's Hospital, Boston, MA, USA.

PubMed

Insights

Anastomotic ulcers (AUs) affect 5.3% of pediatric intestinal failure (IF) patients. Increased bowel length and longer parenteral nutrition (PN) duration are risk factors, with most AUs managed medically.

Area of Science:

  • Gastroenterology
  • Pediatric Surgery
  • Clinical Nutrition

Background:

  • Anastomotic ulcers (AUs) are a rare complication in pediatric patients with intestinal failure (IF).
  • Previous research on AUs consists of small, descriptive studies.
  • Identifying risk factors and treatment strategies for AUs is crucial for managing IF patients.

Purpose of the Study:

  • To evaluate a large cohort of IF patients to identify risk factors for anastomotic ulcers (AUs).
  • To describe treatment strategies for AUs in children with intestinal failure (IF).

Main Methods:

  • A retrospective, case-control study was conducted involving IF patients in a pediatric intestinal rehabilitation program (2013-2023).
  • Cases were children with IF and peri-anastomotic ulceration confirmed by GI endoscopy, matched with two controls (IF patients without AU) based on sex and time since IF diagnosis.
  • Conditional logistic regression was used to compare risk factors between cases and controls.

Main Results:

  • Out of 588 screened patients, 31 (5.3%) were identified as cases with AUs.
  • Multivariable analysis indicated that AU was associated with increased bowel length (OR 1.65 per 10% increase) and longer duration of parenteral nutrition (PN) (OR 1.68).
  • Most patients (93.5%) were initially managed medically; however, 32.3% required red blood cell transfusions, and 8 patients ultimately required surgery or endoscopic coagulation.

Conclusions:

  • Anastomotic ulcers (AUs) were identified in 5.3% of the studied intestinal failure (IF) patients.
  • Increased percent expected bowel length and longer duration of parenteral nutrition (PN) were associated with a higher odds of developing AUs.
  • While most AUs can be managed medically, surgical intervention may be necessary for select cases.
Abstract

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
143
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
44
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
55
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
305
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
22
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
44